Trade Summary

3 days ago, Kirn David, serving as See Remarks at 4D Molecular Therapeutics, Inc. (FDMT), sold 69,076 shares at $15.75 per share, for a total transaction value of $1,088,273.27. Following this transaction, Kirn David now holds 825,819 shares of FDMT.

This sale represents a 7.72% decrease in Kirn David's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:06 PM ET, 2 days after the trade was made.

4D Molecular Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.